Andrew L. Hong

3.5k total citations
28 papers, 402 citations indexed

About

Andrew L. Hong is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrew L. Hong has authored 28 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrew L. Hong's work include Chromatin Remodeling and Cancer (6 papers), Renal and related cancers (6 papers) and Renal cell carcinoma treatment (4 papers). Andrew L. Hong is often cited by papers focused on Chromatin Remodeling and Cancer (6 papers), Renal and related cancers (6 papers) and Renal cell carcinoma treatment (4 papers). Andrew L. Hong collaborates with scholars based in United States, Australia and France. Andrew L. Hong's co-authors include Jesse S. Boehm, Kathryn S. Sutton, Tanaz Sharifnia, Corrie Painter, Chang-Hui Shen, Charles W.M. Roberts, Julia Glade Bender, Wendy B. London, AeRang Kim and Brian D. Crompton and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Andrew L. Hong

23 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew L. Hong United States 11 231 105 93 89 63 28 402
Shyamala Navada United States 11 252 1.1× 140 1.3× 70 0.8× 36 0.4× 24 0.4× 49 574
Jeffrey P. Solzak United States 8 167 0.7× 124 1.2× 56 0.6× 117 1.3× 49 0.8× 17 392
Wenyu Di China 13 180 0.8× 93 0.9× 84 0.9× 122 1.4× 28 0.4× 25 360
И. Е. Повереннова Russia 6 176 0.8× 166 1.6× 43 0.5× 59 0.7× 24 0.4× 26 473
Alison Millson United States 12 155 0.7× 64 0.6× 60 0.6× 24 0.3× 25 0.4× 17 339
Laura Baker United States 11 281 1.2× 40 0.4× 31 0.3× 24 0.3× 33 0.5× 17 405
J. Racquel Collins-Underwood United States 5 283 1.2× 77 0.7× 25 0.3× 55 0.6× 21 0.3× 7 571
Song Baik United Kingdom 11 146 0.6× 121 1.2× 37 0.4× 36 0.4× 28 0.4× 12 597
Maxwell Mays United States 5 214 0.9× 172 1.6× 81 0.9× 10 0.1× 62 1.0× 6 676
Parvaneh Nikpour Iran 15 444 1.9× 92 0.9× 32 0.3× 279 3.1× 18 0.3× 72 666

Countries citing papers authored by Andrew L. Hong

Since Specialization
Citations

This map shows the geographic impact of Andrew L. Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew L. Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew L. Hong more than expected).

Fields of papers citing papers by Andrew L. Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew L. Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew L. Hong. The network helps show where Andrew L. Hong may publish in the future.

Co-authorship network of co-authors of Andrew L. Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew L. Hong. A scholar is included among the top collaborators of Andrew L. Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew L. Hong. Andrew L. Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benedetti, Daniel J., Nicholas G. Cost, Peter F. Ehrlich, et al.. (2025). Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials. Nature Reviews Urology. 22(11). 775–788.
2.
Mehta, C. Christina, Milo B. Fasken, Andrew L. Hong, et al.. (2025). Histone H3E50K remodels chromatin to confer oncogenic activity and support an EMT phenotype. NAR Cancer. 7(1). zcaf002–zcaf002. 2 indexed citations
3.
Czaplinski, Jeffrey T., Suzanne J. Forrest, Neerav Shukla, et al.. (2024). TAZNI: A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS10077–TPS10077.
4.
Geller, James I., Andrew L. Hong, Kelly Vallance, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Renal tumors. Pediatric Blood & Cancer. 70(S6). e30586–e30586. 11 indexed citations
5.
Hong, Andrew L., et al.. (2023). Genetics of ABCB1 in Cancer. Cancers. 15(17). 4236–4236. 41 indexed citations
6.
7.
Jones, Robert B., et al.. (2022). Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer. Cancer Research Communications. 2(12). 1569–1578. 6 indexed citations
8.
Hong, Andrew L., et al.. (2022). Bilateral Internal Carotid Artery Agenesis in a Patient With a Family History of Intracranial Pathology. Ochsner Journal. 23(1). 88–91. 1 indexed citations
9.
Kim, Hyun‐Ji, Jian Carrot‐Zhang, Yuxiang Zhang, et al.. (2021). Haplotype-resolved germline and somatic alterations in renal medullary carcinomas. Genome Medicine. 13(1). 114–114. 7 indexed citations
10.
Sutton, Kathryn S., et al.. (2021). Progress Update in Pediatric Renal Tumors. Current Oncology Reports. 23(3). 33–33. 20 indexed citations
11.
Tseng, Yuen‐Yi, Rebecca Deasy, Paula Keskula, et al.. (2020). Abstract 3453: Cancer Cell Line Factory: A systematic approach to create next-generation cancer model at scale. Cancer Research. 80(16_Supplement). 3453–3453. 1 indexed citations
12.
Hong, Andrew L., Jennifer L. Guerriero, Mihir B. Doshi, et al.. (2019). MCL1 and DEDD Promote Urothelial Carcinoma Progression. Molecular Cancer Research. 17(6). 1294–1304. 4 indexed citations
13.
Hong, Andrew L.. (2018). CRISPR in personalized medicine: Industry perspectives in gene editing. Seminars in Perinatology. 42(8). 501–507. 13 indexed citations
14.
Sharifnia, Tanaz, Andrew L. Hong, Corrie Painter, & Jesse S. Boehm. (2017). Emerging Opportunities for Target Discovery in Rare Cancers. Cell chemical biology. 24(9). 1075–1091. 33 indexed citations
15.
Howard, Thomas P., Francisca Vázquez, Aviad Tsherniak, et al.. (2016). Functional Genomic Characterization of Cancer Genomes. Cold Spring Harbor Symposia on Quantitative Biology. 81. 237–246. 13 indexed citations
16.
Harris, Marian H., Steven G. DuBois, Julia Glade Bender, et al.. (2016). Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors. JAMA Oncology. 2(5). 608–608. 119 indexed citations
17.
18.
Kim, Han Sol, Andrew L. Hong, & Jin Bae Park. (2013). Vision-based Line Tracking for an Indoor Micro Quadrotor. Journal of International Council on Electrical Engineering. 3(3). 245–249.
19.
Hong, Andrew L., Aiying Zhang, Yang Ke, Abdeslem El Idrissi, & Chang-Hui Shen. (2011). Downregulation of GABAA β Subunits is Transcriptionally Controlled by Fmr1p. Journal of Molecular Neuroscience. 46(2). 272–275. 24 indexed citations
20.
Hong, Andrew L., Dezheng Huo, Han Jo Kim, et al.. (2007). UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms and Total Bilirubin Levels in an Ethnically Diverse Cohort of Women. Drug Metabolism and Disposition. 35(8). 1254–1261. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shyamala Navada Breakdown of academic impact, for papers by Jeffrey P. Solzak Breakdown of academic impact, for papers by Wenyu Di Breakdown of academic impact, for papers by И. Е. Повереннова Breakdown of academic impact, for papers by Alison Millson Breakdown of academic impact, for papers by Laura Baker Breakdown of academic impact, for papers by J. Racquel Collins-Underwood Breakdown of academic impact, for papers by Song Baik Breakdown of academic impact, for papers by Maxwell Mays Breakdown of academic impact, for papers by Parvaneh Nikpour
Rankless by CCL
2026